BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2291994)

  • 21. [Autologous stem cell transplantation. From bone marrow to selected blood stem cells: 100 consecutive procedures at a single center].
    Geisler CH; Simonsen AC; Mortensen BT; Christensen LD; Ersbøll JK; Andersen NS; Dickmeiss E; Hansen MM
    Ugeskr Laeger; 1996 Apr; 158(18):2546-51. PubMed ID: 8686009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
    Langenmayer I; Weaver C; Buckner CD; Lilleby K; Appelbaum FR; Longin K; Rowley S; Storb R; Singer J; Bensinger WI
    Bone Marrow Transplant; 1995 Feb; 15(2):241-6. PubMed ID: 7773213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial pneumonitis in allogeneic bone marrow transplantation: a report from the Japanese BMT Study Group.
    Teshima H; Masaoka T; Inoue T; Kato S; Naito K; Mori T; Kanamaru A; Saito Y; Ohira M; Moriyama Y
    Bone Marrow Transplant; 1986 Dec; 1(2):179-83. PubMed ID: 2458786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.
    Cervantes F; Shu XO; McGlave PB; Ramsay NK; Miller WJ; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1995 Sep; 16(3):387-92. PubMed ID: 8535311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
    Schouten HC; Armitage JO; Klassen LW; Vaughan WP; Bierman PJ; Weisenburger D; Kessinger A
    Bone Marrow Transplant; 1989 Jan; 4(1):119-21. PubMed ID: 2466510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party.
    Sweetenham JW; Pearce R; Philip T; Proctor SJ; Mandelli F; Colombat P; Goldstone AH
    Bone Marrow Transplant; 1994 Dec; 14(6):981-7. PubMed ID: 7711677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interstitial pneumonitis following allogeneic bone marrow transplantation in the treatment of leukemia based on BMT survey in Japan.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1988 Dec; 164(12):729-33. PubMed ID: 3061043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
    Gisselbrecht C; Lepage E; Brice P; Trédaniel J; Gerota I
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):131-4. PubMed ID: 2455276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT).
    Toren A; Or R; Ackerstein A; Nagler A
    Bone Marrow Transplant; 1997 Jul; 20(1):67-9. PubMed ID: 9232260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma.
    Armitage JO
    Bone Marrow Transplant; 1992; 10 Suppl 1():62-3. PubMed ID: 1521093
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation.
    Nenadov Beck M; Meresse V; Hartmann O; Gaultier C
    Bone Marrow Transplant; 1995 Dec; 16(6):771-5. PubMed ID: 8750268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests.
    Ghalie R; Szidon JP; Thompson L; Nawas YN; Dolce A; Kaizer H
    Bone Marrow Transplant; 1992 Oct; 10(4):359-65. PubMed ID: 1422492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful autologous transplantation of immunomagnetic bead purged bone marrow in non-Hodgkin's lymphoma.
    Ogniben E; Hohaus S; Kvalheim G; Dörken B; Haas R
    Prog Clin Biol Res; 1992; 377():189-95. PubMed ID: 1438415
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
    Lu C; Braine HG; Kaizer H; Saral R; Tutschka PJ; Santos GW
    Cancer Treat Rep; 1984 May; 68(5):711-7. PubMed ID: 6373004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
    J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation.
    Phillips GL; Fay JW; Herzig RH; Lazarus HM; Wolff SN; Lin HS; Shina DC; Glasgow GP; Griffith RC; Lamb CW
    Blood; 1990 Feb; 75(4):831-8. PubMed ID: 2302456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.